{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:47:25Z","timestamp":1769168845507,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.rdc.2014.12.003","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T23:50:13Z","timestamp":1422921013000},"page":"213-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Determining Respiratory Impairment in Connective Tissue Disease\u2013Associated Interstitial Lung Disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Deborah","family":"Assayag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Ryerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2014.12.003_bib1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.rmed.2010.03.027","article-title":"Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease","volume":"104","author":"Swigris","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2014.12.003_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1183\/09031936.03.00026703","article-title":"Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis","volume":"22","author":"Cottin","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2014.12.003_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","article-title":"Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality: a retrospective study based on registry data","volume":"52","author":"Palm","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2014.12.003_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","article-title":"An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea","volume":"185","author":"Parshall","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.rmed.2004.10.018","article-title":"The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis","volume":"99","author":"Papiris","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib7","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.apmr.2014.01.016","article-title":"Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to medical research council dyspnea grade","volume":"95","author":"Kozu","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.rdc.2014.12.003_bib8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/resp.12360","article-title":"Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease","volume":"9","author":"Holland","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.rdc.2014.12.003_bib9","first-page":"121578","volume":"2013","author":"Pan","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.rdc.2014.12.003_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib11","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1183\/09031936.00027913","article-title":"Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis","volume":"42","author":"Cordier","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2014.12.003_bib12","first-page":"1250","article-title":"Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years","volume":"33","author":"Rajasekaran","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.12.003_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2169\/internalmedicine.39.213","article-title":"Clinical evaluation of idiopathic interstitial pneumonia and interstitial pneumonia associated with collagen vascular disease using logistic regression analysis","volume":"39","author":"Ishioka","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajim.20922","article-title":"Lung diffusing capacity relates better to short-term progression on HRCT abnormalities than spirometry in mild asbestosis","volume":"54","author":"Nogueira","year":"2011","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2014.12.003_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib18","first-page":"S53","article-title":"Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis","volume":"29","author":"Deuschle","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2014.12.003_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3899\/jrheum.081221","article-title":"Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis","volume":"36","author":"Schoindre","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.12.003_bib20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1183\/09031936.00131813","article-title":"6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis","volume":"43","author":"du Bois","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2014.12.003_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/ajrccm.167.10.950","article-title":"ATS\/ACCP statement on cardiopulmonary exercise testing","volume":"167","author":"Ross","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib22","doi-asserted-by":"crossref","first-page":"e14293","DOI":"10.1371\/journal.pone.0014293","article-title":"Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing","volume":"5","author":"Dumitrescu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.rdc.2014.12.003_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000350445","article-title":"Distinguishing pulmonary hypertension in interstitial lung disease by ventilation and perfusion defects measured by cardiopulmonary exercise testing","volume":"86","author":"Armstrong","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.rdc.2014.12.003_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiology.171.1.2928513","article-title":"Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography","volume":"171","author":"Mathieson","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.rdc.2014.12.003_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1378\/chest.107.1.113","article-title":"Radiation exposure in standard and high-resolution chest CT scans","volume":"107","author":"van der Bruggen-Bogaarts","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2014.12.003_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiol.13130187","article-title":"Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern","volume":"270","author":"Assayag","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.rdc.2014.12.003_bib27","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2014.12.003_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/art.21322","article-title":"Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia","volume":"53","author":"Kocheril","year":"2005","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2014.12.003_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/thoraxjnl-2013-203843","article-title":"Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants","volume":"69","author":"Walsh","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.rdc.2014.12.003_bib30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccm.2010.04.002","article-title":"Utility of bronchoalveolar lavage in evaluation of patients with connective tissue diseases","volume":"31","author":"Kowal-Bielecka","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0034-1371543","article-title":"Pulmonary pathology in connective tissue disease","volume":"35","author":"Urisman","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2014.12.003_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1378\/chest.13-2626","article-title":"Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review","volume":"146","author":"Winstone","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2014.12.003_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/resp.12234","article-title":"Predictors of mortality in rheumatoid arthritis-related interstitial lung disease","volume":"19","author":"Assayag","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.rdc.2014.12.003_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-gap model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2014.12.003_bib36","doi-asserted-by":"crossref","first-page":"406927","DOI":"10.1155\/2013\/406927","article-title":"Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease","volume":"2013","author":"Chen","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.rdc.2014.12.003_bib37","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics. A large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2014.12.003_bib38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/01.bor.0000144760.37777.fa","article-title":"Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance","volume":"16","author":"Cepeda","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2014.12.003_bib39","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3109\/s10165-012-0756-0","article-title":"Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis\/dermatomyositis","volume":"23","author":"Arai","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.rdc.2014.12.003_bib40","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1183\/09031936.00004711","article-title":"Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis","volume":"38","author":"Tiev","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2014.12.003_bib41","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3899\/jrheum.120997","article-title":"Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?","volume":"40","author":"Elhaj","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.12.003_bib42","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/09031936.00019210","article-title":"Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome","volume":"37","author":"Tsuchiya","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2014.12.003_bib43","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2012","journal-title":"N\u00a0Engl J Med"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X14001240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X14001240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:14:36Z","timestamp":1760181276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X14001240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0889857X14001240"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2014.12.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining Respiratory Impairment in Connective Tissue Disease\u2013Associated Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2014.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}